Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

Staging and surgical approaches in gastric cancer: a clinical practice guideline.

Coburn N, Cosby R, Klein L, Knight G, Malthaner R, Mamazza J, Mercer CD, Ringash J.

Curr Oncol. 2017 Oct;24(5):324-331. doi: 10.3747/co.24.3736. Epub 2017 Oct 25.

2.
3.

Gastroduodenal neuroendocrine neoplasms, including gastrinoma - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).

Lipiński M, Rydzewska G, Foltyn W, Andrysiak-Mamos E, Bałdys-Waligórska A, Bednarczuk T, Blicharz-Dorniak J, Bolanowski M, Boratyn-Nowicka A, Borowska M, Cichocki A, Ćwikła JB, Falconi M, Handkiewicz-Junak D, Hubalewska-Dydejczyk A, Jarząb B, Junik R, Kajdaniuk D, Kamiński G, Kolasińska-Ćwikła A, Kowalska A, Król R, Królicki L, Kunikowska J, Kuśnierz K, Lampe P, Lange D, Lewczuk-Myślicka A, Lewiński A, Londzin-Olesik M, Marek B, Nasierowska-Guttmejer A, Nowakowska-Duława E, Pilch-Kowalczyk J, Poczkaj K, Rosiek V, Ruchała M, Siemińska L, Sowa-Staszczak A, Starzyńska T, Steinhof-Radwańska K, Strzelczyk J, Sworczak K, Syrenicz A, Szawłowski A, Szczepkowski M, Wachuła E, Zajęcki W, Zemczak A, Zgliczyński W, Kos-Kudła B.

Endokrynol Pol. 2017;68(2):138-153. doi: 10.5603/EP.2017.0016.

4.

[Comments on the seven clinical questions & answers in Japanese gastric treatment guidelines of the 4th edition].

Xu JM.

Zhonghua Zhong Liu Za Zhi. 2017 Mar 23;39(3):236-238. doi: 10.3760/cma.j.issn.0253-3766.2017.03.016. Chinese.

PMID:
28316227
5.

First comprehensive guideline released for the assessment of HER2 in patients with GEA.

Washington MK.

MLO Med Lab Obs. 2017 Mar;49(3):30-1. No abstract available.

PMID:
29924569
6.

[The 2016 International Gastric Cancer Association and American Joint Committee on Cancer gastric cardiac carcinoma pathologic staging guidelines: progress and limitation].

Huang Q, Zhou XL, Fan XS, Guo LC, Ding YL, Zhang YF.

Zhonghua Bing Li Xue Za Zhi. 2017 Feb 8;46(2):73-75. doi: 10.3760/cma.j.issn.0529-5807.2017.02.001. Chinese. No abstract available.

PMID:
28173662
7.

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology.

Bartley AN, Washington MK, Colasacco C, Ventura CB, Ismaila N, Benson AB 3rd, Carrato A, Gulley ML, Jain D, Kakar S, Mackay HJ, Streutker C, Tang L, Troxell M, Ajani JA.

J Clin Oncol. 2017 Feb;35(4):446-464. doi: 10.1200/JCO.2016.69.4836. Epub 2016 Nov 14.

PMID:
28129524
8.

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.

Bartley AN, Washington MK, Ventura CB, Ismaila N, Colasacco C, Benson AB 3rd, Carrato A, Gulley ML, Jain D, Kakar S, Mackay HJ, Streutker C, Tang L, Troxell M, Ajani JA.

Am J Clin Pathol. 2016 Dec;146(6):647-669. doi: 10.1093/ajcp/aqw206. Epub 2016 Nov 14. Review.

9.

[CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY FOR MEDICAL ONCOLOGY CLINICAL GUIDELINES Part IV: planocellular head and neck cancer, oesophageal cancer, gastric cancer, colorectal cancer].

Silovski T, Pleština S, Belev B, Dintinjana RD, Kurbel S, Županc D, Vrdoljak DV, Škegro M, Vidović M, Šeparović R, Vrbanec D.

Lijec Vjesn. 2017 Jan-Feb;139(1-2):12-7. Croatian.

PMID:
30148585
10.

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.

Bartley AN, Washington MK, Ismaila N, Ajani JA.

J Oncol Pract. 2017 Jan;13(1):53-57. doi: 10.1200/JOP.2016.018929. Epub 2016 Nov 29. No abstract available.

PMID:
27907277
11.

Compliance with Guidelines of Enhanced Recovery After Surgery in Elderly Patients Undergoing Gastrectomy.

Jeong O, Park YK, Jung MR, Ryu SY.

World J Surg. 2017 Apr;41(4):1040-1046. doi: 10.1007/s00268-016-3845-y.

PMID:
27882418
12.

Expert consensus on perioperative medications during endoscopic submucosal dissection for gastric lesions (2015, Suzhou, China).

Bai Y, Cai JT, Chen YX, Gao F, Guo XZ, Guo XG, Han Y, Hao JY, He SX, Ji M, Jiang B, Jiang HQ, Jin ZD, Li YQ, Li ZS, Liao Z, Liu F, Liu ZG, Luo HS, Lv B, Lv NH, Ren X, Sheng JQ, Shi RH, Tian A, Wang FY, Wang GQ, Yang AM, Zhang GX, Zhang ZY, Zhi FC, Zou DW, Zou XP; Chinese Society of Digestive Endoscopy.

J Dig Dis. 2016 Dec;17(12):784-789. doi: 10.1111/1751-2980.12430. No abstract available.

PMID:
27860300
13.

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.

Bartley AN, Washington MK, Ventura CB, Ismaila N, Colasacco C, Benson AB 3rd, Carrato A, Gulley ML, Jain D, Kakar S, Mackay HJ, Streutker C, Tang L, Troxell M, Ajani JA.

Arch Pathol Lab Med. 2016 Dec;140(12):1345-1363. Epub 2016 Nov 14.

PMID:
27841667
14.

Postgastrectomy follow-up in the West: evidence base, guidelines, and daily practice.

Nilsson M.

Gastric Cancer. 2017 Mar;20(Suppl 1):135-140. doi: 10.1007/s10120-016-0654-9. Epub 2016 Oct 7. Review.

15.

Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.

Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Korn WM, Leong S, Linn C, Lockhart AC, Ly QP, Mulcahy MF, Orringer MB, Perry KA, Poultsides GA, Scott WJ, Strong VE, Washington MK, Weksler B, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H.

J Natl Compr Canc Netw. 2016 Oct;14(10):1286-1312.

PMID:
27697982
16.

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; ESMO Guidelines Committee.

Ann Oncol. 2016 Sep;27(suppl 5):v38-v49. No abstract available.

PMID:
27664260
17.

[CLINICAL RECOMMENDATIONS FOR DIAGNOSIS, TREATMENT AND MONITORING OF PATIENTS WITH ESOPHAGEAL AND ESOPHAGOGASTRIC JUNCTION CANCERS].

Bišof V, Juretić A, Stančić-Rokotov D, Rustemović N, Miletić D, Boban M, Omrčen T, Razumović JJ, Pavlović I, Fröbe A, Čonkaš M, Rakušić Z, Gugić D.

Lijec Vjesn. 2016 Sep-Oct;138(9-10):233-9. Croatian.

PMID:
30148543
18.

[Radiotherapy in cancers of the oesophagus, the gastric cardia and the stomach].

Créhange G, Huguet F, Quero L, N'Guyen TV, Mirabel X, Lacornerie T.

Cancer Radiother. 2016 Sep;20 Suppl:S161-8. doi: 10.1016/j.canrad.2016.07.039. Epub 2016 Aug 11. French.

PMID:
27523409
19.

[Guidelines for HER2 detection in gastric cancer(2016)].

Guideline Recommendations for HER2 Detection in Gastric Cancer Group.

Zhonghua Bing Li Xue Za Zhi. 2016 Aug 8;45(8):528-32. doi: 10.3760/cma.j.issn.0529-5807.2016.08.007. Chinese. No abstract available.

PMID:
27510777
20.

Japanese gastric cancer treatment guidelines 2014 (ver. 4).

Japanese Gastric Cancer Association.

Gastric Cancer. 2017 Jan;20(1):1-19. doi: 10.1007/s10120-016-0622-4. Epub 2016 Jun 24. No abstract available.

Supplemental Content

Loading ...
Support Center